4 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Child: new trials by email Literature Review of Child trials Research Report on Child
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melatonin vs Midazolam in Children Undergoing Tonsillectomy Melatonin group, Midazolam group, Control group - Emergence Delirium, Anesthesia, Child | Phase 3 | Not yet recruiting | Ain Shams University | 195 | 2026-03-01 | 2026-01-13 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study Small intestinal release peppermint oil, Peppermint sweets, Placebo - Irritable Bowel Syndrome, Functional Abdominal Pain Syndrome | Phase 3 | Completed | St. Antonius Hospital | 228 | 2022-05-12 | 2025-05-30 |
| Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy Vayarin®, supplementation of n-3 PUFA, PLACEBO - Attention Deficit Disorder With Hyperactivity, ADHD Inattention or Mixed Type | Phase 3 | Completed | Hospices Civils de Lyon | 77 | 2015-03-01 | 2025-08-06 |
| Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT lipoprostaglandin E1 - Veno-occlusive Disease, Child | Phase 2 / Phase 3 | Unknown | Seoul National University Hospital | 30 | 2015-01-01 | 2021-03-30 |
| An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children face-to-face meetings and access to a website - Child, Obesity | Phase 3 | Completed | University of Wisconsin, Madison | 77 | 2013-02-01 | 2015-07-29 |
| Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections telithromycin (HMR3647) - Infections, Child | Phase 3 | Completed | Sanofi | 111 | 2004-08-01 | 2009-04-03 |
Anxiety Disorders (1) · Attention Deficit Disorder with Hyperactivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Emergence Delirium (1) · Epilepsy (1) · Infections (1) · Irritable Bowel Syndrome (1) · Obesity (1) · Overweight (1) · Respiratory Tract Infections (1) · Sinusitis (1) · Skin Diseases (1)
Mental Disorders (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Body Weight (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Confusion (1) · Delirium (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1)
Brentuximab Vedotin (1) · Control Groups (1) · Cyclophosphamide (1) · Dacarbazine (1) · Doxorubicin (1) · Etoposide (1) · Injections (1) · Prednisone (1) · peppermint oil (1) · telithromycin (1) · tislelizumab (1)
Ain Shams University (1) · Children's Cancer Group, China (1) · Hospices Civils de Lyon (1) · Sanofi (1) · Seoul National University Hospital (1) · St. Antonius Hospital (1) · University of Wisconsin, Madison (1)
China (1) · France (1) · Japan (1) · Netherlands (1) · South Korea (1) · United States (1)
Arine Vlieger, MD, PhD (1) · Ellen R Wald, MD (1) · Hyoung Jin Kang, MD, PhD (1) · Norifumi Yamamoto (1) · Sylvain Rheims, MD (1)
PMID 17332205, PMID 17595270, PMID 21646253, PMID 37058600, PMID 38173190, PMID 41610933